Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

Condition:   Hypertensive Emergency-associated Hemolytic Uremic Syndrome Interventions:   Drug: Soliris®;   Drug: Renin angiotensin system blockers Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials